Bench to bedside: the development of rapamycin and its application to stent restenosis. [electronic resource]
Producer: 20010913Description: 852-5 p. digitalISSN:- 1524-4539
- Angioplasty, Balloon, Coronary -- adverse effects
- Animals
- Calcineurin Inhibitors
- Carrier Proteins -- metabolism
- Cell Cycle Proteins -- metabolism
- Cell Division -- drug effects
- Cell Movement -- drug effects
- Clinical Trials as Topic
- Clopidogrel
- Coronary Artery Disease -- surgery
- Cyclin-Dependent Kinase Inhibitor p27
- Down-Regulation -- drug effects
- Graft Occlusion, Vascular -- diagnosis
- Humans
- Hyperplasia -- diagnosis
- Macromolecular Substances
- Phosphotransferases (Alcohol Group Acceptor)
- Platelet Aggregation Inhibitors -- therapeutic use
- Signal Transduction -- drug effects
- Sirolimus -- metabolism
- Stents -- adverse effects
- TOR Serine-Threonine Kinases
- Tacrolimus -- pharmacology
- Tacrolimus Binding Protein 1A -- metabolism
- Ticlopidine -- analogs & derivatives
- Tumor Suppressor Proteins
- Tunica Media -- drug effects
- Vascular Patency -- drug effects
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.